Can Biomarkers Give Early Heads-Up on Immune Checkpoint Inhibitor Myocarditis?

(MedPage Today) -- In the quest to catch myocarditis earlier during immune checkpoint inhibitor (ICI) therapy for cancer, researchers have found a potential role for routinely measured biomarkers. Of 2,606 consecutive ICI recipients at Michigan...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news